Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials. [electronic resource]
Producer: 20210604Description: 24 p. digitalISSN:- 1471-2172
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Child
- Child, Preschool
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Female
- Glycolipids -- immunology
- Humans
- Immunoglobulins, Intravenous -- immunology
- Male
- Middle Aged
- Primary Immunodeficiency Diseases -- immunology
- Quality of Life
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.